Link between CFTR mutations and ABPA: A systematic review and meta-analysis

Mycoses

Volumn 55, Issue 4, 2012, Pages 357-365

  Agarwal, Ritesh ^a   Khan, Ajmal ^a   Aggarwal, Ashutosh N ^a   Gupta, Dheeraj ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Allergic bronchopulmonary aspergillosis; Aspergillus; Asthma; Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ARTICLE; ASTHMA; EMBASE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC LINKAGE; HUMAN; MEDLINE; META ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; PUBLISHING; SAMPLE SIZE; SYSTEMATIC REVIEW;

ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASTHMA; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; PUBLICATION BIAS;

ASPERGILLUS;

EID: 84862247878     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2011.02130.x     Document Type: Article

References (73)

1. Agarwal R. Allergic bronchopulmonary aspergillosis. In: Jindal SK, Shankar PS, Raoof S, Gupta D, Aggarwal AN, Agarwal R (eds), Textbook of Pulmonary and Critical Care Medicine. New Delhi: Jaypee Publications, 2010: 947-70.
2. Moss RB. Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis. Curr Opin Pulm Med 2010; 16: 598-603.
3. Patterson K, Strek ME. Allergic bronchopulmonary aspergillosis. Proc Am Thorac Soc 2010; 7: 237-44.
4. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 2009; 135: 805-26.
5. Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis 2009; 13: 936-44.
6. Agarwal R. Controversies in allergic bronchopulmonary aspergillosis. Int J Respir Care 2010; 6: 53-4, 6-63.
7. Hinson KFW, Moon AJ, Plummer NS. Broncho-pulmonary aspergillosis; a review and a report of eight new cases. Thorax 1952; 7: 317-33.
8. Agarwal R, Chakrabarti A. Clinical manifestations and natural history of allergic bronchopulmonary aspergillosis. In: Pasqualotto AC (ed.), Aspergillosis: From Diagnosis to Prevention. New York: Springer, 2009: 707-24.
9. Patterson R, Greenberger PA, Halwig JM, Liotta JL, Roberts M. Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 1986; 146: 916-8.
10. Henderson AH. Allergic aspergillosis; review of 32 cases. Thorax 1968; 23: 513-23.
11. Kramer MN, Kurup VP, Fink JN. Allergic bronchopulmonary aspergillosis from a contaminated dump site. Am Rev Respir Dis 1989; 140: 1086-8.
12. Kagen SL, Kurup VP, Sohnle PG, Fink JN. Marijuana smoking and fungal sensitization. J Allergy Clin Immunol 1983; 71: 389-93.
13. Allmers H, Huber H, Baur X. Two year follow-up of a garbage collector with allergic bronchopulmonary aspergillosis (ABPA). Am J Ind Med 2000; 37: 438-42.
14. Bateman ED. A new look at the natural history of Aspergillus hypersensitivity in asthmatics. Respir Med 1994; 88: 325-7.
15. Knutsen AP. Genetic and respiratory tract risk factors for aspergillosis: ABPA and asthma with fungal sensitization. Med Mycol 2006; 44(Suppl. 1): 61-70.
16. Knutsen AP, Slavin RG. Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis. Clin Dev Immunol 2011; 2011: 843763.
17. Shah A, Kala J, Sahay S, Panjabi C. Frequency of familial occurrence in 164 patients with allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol 2008; 101: 363-9.
18. Lommatzsch ST, Aris R. Genetics of cystic fibrosis. Semin Respir Crit Care Med 2009; 30: 531-8.
19. Chen JH, Schulman H, Gardner P. A cAMP-regulated chloride channel in lymphocytes that is affected in cystic fibrosis. Science 1989; 243: 657-60.
20. Moss RB, Hsu YP, Olds L. Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes. Clin Exp Immunol 2000; 120: 518-25.
21. Allard JB, Poynter ME, Marr KA, Cohn L, Rincon M, Whittaker LA. Aspergillus fumigatus generates an enhanced Th2-biased immune response in mice with defective cystic fibrosis transmembrane conductance regulator. J Immunol 2006; 177: 5186-94.
22. Mueller C, Braag SA, Keeler A, Hodges C, Drumm M, Flotte TR. Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses. Am J Respir Cell Mol Biol 2011; 44: 922-9.
23. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-48.
24. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
25. Deeks JJ, Higgins JPT, Altman DG. Analysing and presenting results. In: Alderson P, Green S, Higgins JPT (eds), Cochrane Reviewers' Handbook 422 (updated March 2004). Chichester, UK: John Wiley & Sons, Ltd, 2004: 68-139.
26. Fleiss JL. Analysis of data from multiclinic trials. Control Clin Trials 1986; 7: 267-75.
27. Dear K, Begg C. An approach to assessing publication bias prior to performing a meta-analysis. Stat Sci 1992; 7: 237-45.
28. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
29. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.
30. Miller PW, Hamosh A, Macek M Jr et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet 1996; 59: 45-51.
31. Aron Y, Bienvenu T, Hubert D, Dusser D, Dall'Ava J, Polla BS. HLA-DR polymorphism in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1999; 104: 891-2.
32. Marchand E, Verellen-Dumoulin C, Mairesse M et al. Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis. Chest 2001; 119: 762-7.
33. Eaton TE, Weiner Miller P, Garrett JE, Cutting GR. Cystic fibrosis transmembrane conductance regulator gene mutations: do they play a role in the aetiology of allergic bronchopulmonary aspergillosis? Clin Exp Allergy 2002; 32: 756-61.
34. Lebecque P, Pepermans X, Marchand E, Leonard A, Leal T. ABPA in adulthood: a CFTR-related disorder. Thorax 2011; 66: 540-1.
35. Starke ID. Asthma and allergic aspergillosis in monozygotic twins. Br J Dis Chest 1985; 79: 295-300.
36. Shah A, Khan ZU, Chaturvedi S, Malik GB, Randhawa HS. Concomitant allergic Aspergillus sinusitis and allergic bronchopulmonary aspergillosis associated with familial occurrence of allergic bronchopulmonary aspergillosis. Ann Allergy 1990; 64: 507-12.
37. Agarwal R. Severe asthma with fungal sensitization. Curr Allergy Asthma Rep 2011; 11: 403-13.
38. Knutsen AP, Chauhan B, Slavin RG. Cell-mediated immunity in allergic bronchopulmonary aspergillosis. Immunol Allergy Clin North Am 1998; 18: 575-99.
39. Rapaka RR, Kolls JK. Pathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis: current understanding and future directions. Med Mycol 2009; 47(Suppl 1): S331-7.
40. Agarwal R. Allergic bronchopulmonary aspergillosis: lessons learnt from genetics. Indian J Chest Dis Allied Sci 2011; 53: 137-40.
41. Paranjape SM, Zeitlin PL. Atypical cystic fibrosis and CFTR-related diseases. Clin Rev Allergy Immunol 2008; 35: 116-23.
42. Chillon M, Casals T, Mercier B et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 1995; 332: 1475-80.
43. Castellani C, Cuppens H, Macek M Jr et al. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros 2008; 7: 179-96.
44. Dahl M, Tybjaerg-Hansen A, Lange P, Nordestgaard BG. DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma. Lancet 1998; 351: 1911-3.
45. Lazaro C, de Cid R, Sunyer J et al. Missense mutations in the cystic fibrosis gene in adult patients with asthma. Hum Mutat 1999; 14: 510-9.
46. Jorissen MB, De Boeck K, Cuppens H. Genotype-phenotype correlations for the paranasal sinuses in cystic fibrosis. Am J Respir Crit Care Med 1999; 159: 1412-6.
47. Wang X, Moylan B, Leopold DA et al. Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA 2000; 284: 1814-9.
48. Wang X, Kim J, McWilliams R, Cutting GR. Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation. Arch Otolaryngol Head Neck Surg 2005; 131: 237-40.
49. Davis PB, Vargo K. Pulmonary abnormalities in obligate heterozygotes for cystic fibrosis. Thorax 1987; 42: 120-5.
50. Schroeder SA, Gaughan DM, Swift M. Protection against bronchial asthma by CFTR delta F508 mutation: a heterozygote advantage in cystic fibrosis. Nat Med 1995; 1: 703-5.
51. de Almeida MB, Bussamra MH, Rodrigues JC. Allergic bronchopulmonary aspergillosis in paediatric cystic fibrosis patients. Paediatr Respir Rev 2006; 7: 67-72.
52. Bienvenu T, Sermet-Gaudelus I, Burgel PR et al. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2010; 181: 1078-84.
53. Garred P, Pressler T, Madsen HO et al. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 1999; 104: 431-7.
54. Drumm ML, Konstan MW, Schluchter MD et al. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 2005; 353: 1443-53.
55. Dorfman R, Sandford A, Taylor C et al. Complex two-gene modulation of lung disease severity in children with cystic fibrosis. J Clin Invest 2008; 118: 1040-9.
56. Cutting GR. Modifier genetics: cystic fibrosis. Annu Rev Genomics Hum Genet 2005; 6: 237-60.
57. Wright FA, Strug LJ, Doshi VK et al. Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. Nat Genet 2011; 43: 539-46.
58. Madan T, Kaur S, Saxena S et al. Role of collectins in innate immunity against aspergillosis. Med Mycol 2005; 43(Suppl 1): S155-63.
59. Sambatakou H, Pravica V, Hutchinson IV, Denning DW. Cytokine profiling of pulmonary aspergillosis. Int J Immunogenet 2006; 33: 297-302.
60. Vaid M, Kaur S, Sambatakou H, Madan T, Denning DW, Sarma PU. Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis. Clin Chem Lab Med 2007; 45: 183-6.
61. Agarwal R, Gupta D, Aggarwal AN, Saxena AK, Chakrabarti A, Jindal SK. Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients. Chest 2007; 132: 1183-90.
62. Agarwal R, Gupta D, Aggarwal AN et al. Clinical significance of decline in serum IgE Levels in allergic bronchopulmonary aspergillosis. Respir Med 2010; 104: 204-10.
63. Agarwal R, Khan A, Gupta D, Aggarwal AN, Saxena AK, Chakrabarti A. An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus. PLoS ONE 2010; 5: e15346.
64. Green DM, McDougal KE, Blackman SM et al. Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients. Respir Res 2010; 11: 140.
65. Chauhan B, Knutsen A, Hutcheson PS, Slavin RG, Bellone CJ. T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. J Clin Invest 1996; 97: 2324-31.
66. Chauhan B, Santiago L, Kirschmann DA et al. The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis. J Immunol 1997; 159: 4072-6.
67. Chauhan B, Santiago L, Hutcheson PS et al. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2000; 106: 723-9.
68. Chauhan B, Hutcheson PS, Slavin RG, Bellone CJ. T-cell receptor bias in patients with allergic bronchopulmonary aspergillosis. Hum Immunol 2002; 63: 286-94.
69. Saxena S, Madan T, Shah A, Muralidhar K, Sarma PU. Association of polymorphisms in the collagen region of SP-A2 with increased levels of total IgE antibodies and eosinophilia in patients with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2003; 111: 1001-7.
70. Brouard J, Knauer N, Boelle PY et al. Influence of interleukin-10 on Aspergillus fumigatus infection in patients with cystic fibrosis. J Infect Dis 2005; 191: 1988-91.
71. Kaur S, Gupta VK, Shah A, Thiel S, Sarma PU, Madan T. Elevated levels of mannan-binding lectin [corrected] (MBL) and eosinophilia in patients of bronchial asthma with allergic rhinitis and allergic bronchopulmonary aspergillosis associate with a novel intronic polymorphism in MBL. Clin Exp Immunol 2006; 143: 414-9.
72. Knutsen AP, Kariuki B, Consolino JD, Warrier MR. IL-4 alpha chain receptor (IL-4Ralpha) polymorphisms in allergic bronchopulmonary sspergillosis. Clin Mol Allergy 2006; 4: 3.
73. Carvalho A, Pasqualotto AC, Pitzurra L, Romani L, Denning DW, Rodrigues F. Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis 2008; 197: 618-21.